This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Institut national de la recherche scientifique directory, so their courses may be missing. Find their university profile.
Latest papers
O-GlcNAcylation: A Nutrient-Sensitive Metabolic Rheostat in Antiviral Immunity and Viral Pathogenesis.
Cells · 2025 · senior author
Rational therapeutic targeting of myeloid cells in glioblastoma: challenges and perspectives.
Frontiers in immunology · 2025 · senior author
THBS1+ myeloid cells expand in SLD hepatocellular carcinoma and contribute to immunosuppression and unfavorable prognosis through TREM1.
Cell reports · 2024 · senior author
Latest funding
- $1,216,350
Myeloid cells immune and metabolic targets in glioblastoma progression
CIHR · 2024 · Nominated PI
3 publications.
O-GlcNAcylation: A Nutrient-Sensitive Metabolic Rheostat in Antiviral Immunity and Viral Pathogenesis.
Odo TI, Saleh M
Rational therapeutic targeting of myeloid cells in glioblastoma: challenges and perspectives.
Akay F, Saleh M
THBS1+ myeloid cells expand in SLD hepatocellular carcinoma and contribute to immunosuppression and unfavorable prognosis through TREM1.
Giraud J, Chalopin D, Ramel E, Boyer T, Zouine A, Derieppe MA, Larmonier N, Adotevi O, Le Bail B, Blanc JF, Laurent C, Chiche L, Derive M, Nikolski M, Saleh M
Myeloid cells immune and metabolic targets in glioblastoma progression
Principal investigators: Saleh, Maya
Keywords: Glioblastoma; Inflammation; Metabolism; Myeloid Cells
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.